SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-109203
Filing Date
2023-04-21
Accepted
2023-04-21 07:00:58
Documents
8
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d353395ddef14a.htm DEF 14A 511569
2 GRAPHIC g353395dsp2.jpg GRAPHIC 3218
3 GRAPHIC g353395dsp2a.jpg GRAPHIC 949
4 GRAPHIC g353395dsp2b.jpg GRAPHIC 823
5 GRAPHIC g353395dsp2c.jpg GRAPHIC 1228
6 GRAPHIC g353395dsp2d.jpg GRAPHIC 1152
7 GRAPHIC g353395dsp3.jpg GRAPHIC 966
8 GRAPHIC g353395g01a02.jpg GRAPHIC 35074
  Complete submission text file 0001193125-23-109203.txt   573241
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39103 | Film No.: 23834488
SIC: 2836 Biological Products, (No Diagnostic Substances)